Role Of Endocanabinoid System In Diabetes Mellitus
Main Article Content
Abstract
Long-term consequences of diabetes are very harmful and persistent, therefore preventing them requires more than just tight glycemic management. One of the most prevalent fatal effects of diabetes, diabetic cardiomyopathy is the main cause of death in people with diabetes. Type 1 and 2 cannabinoid receptors, in addition to other factors. Nonetheless, research into the endocannabinoid system's potential impact on diabetic cardiomyopathy remains limited. In order to better understand how cannabinoids and the endocannabinoid system may play a role in the etiology and progression of diabetic cardiomyopathy, this review attempts to do so.
Article Details
All articles published in NVEO are licensed under Copyright Creative Commons Attribution-NonCommercial 4.0 International License.